维普期刊资源整合服务平台（V6.5）

70篇 您的检索式：作者名="Porta MG"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Process parameters and morphology in amoxicillin micro and submicro particles generation by supercritical antisolvent precipitation显示文摘	Reverchon E Della Porta G Falivene MG	2000	J Supercrit Fluids2000，17，：	2
2	Clinical relevance of anemia and transfusion iron overload in myelodysplastic syn- dromes显示文摘	Cazzola M Della Porta MG Malcovati L	2008	Hematology Am Soc Hematol Educ Program2008，1，：	1
3	Importance of classical morphology in the diagnosis of myelodysplastic syndrome 显示文摘	Invernizzi R Quaglia F Porta MG	2015	Mediterr J Hematol Infect Dis2015，7，20：	1
4	Multicenter validation of a reproducibleflow cytometric score for the diagnosis of low-grademyelodysplastic syndromes:results of a EuropeanLeukemia NET study显示文摘	DELLA PORTA MG PICONE C PASCUTTOC	2012	Haematologica2012，97，8：	1
5	Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria:a basis for clinical decision making显示文摘	Malcovati L Della Porta MG Pascutto C		0，，30：	1
6	Prognosticimpact of pre-transplantation transfusion history and secondary ironoverload in patients with myelodysplastic syndrome undergoing allo-geneic stem cell transplantation: a GITMO study 显示文摘	Alessandrino EP Della Porta MG Bacigalupo A	2010	Haematologi-ca2010，95，3：	1
7	Gene polymorphisms infolate metabolizing enzymes in adult acute lymphoblasticleukemia:effects on methotrexate-related toxicity and sur-vival显示文摘	Ongaro A De Mattei M Della Porta MG Rigolin G Am-brosio C Di Raimondo F	2009	Haematologica2009，94，10：	1
8	Predicting survival and leukemic evolution in patients with myelodysplastic syndrome显示文摘	Malcovati L Della Porta MG Cazzola M		0，，12：	1
9	Myelodysplastic syndromes and bone marrow microenvironment显示文摘	Della Porta MG		0，，11：	1
10	Flow cytometric analysis of peripheral blood dendritic cells in patients with severe sepsis显示文摘	Riccardi F Della Porta MG Rovati B		0，，1：	1
11	Prognostic factors and life expectancy in myelodysplastic syndromes c\|assified according to WHO criteria: a basis for clinical decision making 显示文摘	MALCOVATI L PORTA MG PASCUTTO C	2005	J Clin 0ncol2005，23，30：	1
12	Prognostic factors and Life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making显示文摘	Malcovati L Porta MG Pascutto C	2005	J Clin Oncol2005，23，30：	1
13	Predicting survival and leukemic evolution in patients with myelodysplastic syndrome显示文摘	Malcovati L Della Porta MG Cazzola M	2006	Haematalogica2006，91，：	1
14	Flow eytometric analy- sis of peripheral blood dendritic cells in patients with severe sepsis 显示文摘	Rieeardi F Della Porta MG Rovati B	2011	Cytometry B Clin Cytom2011，80，1：	1
15	Importance of classical morphology in the diagnosis of myelodysplastic syndrome 显示文摘	Invernizzi R Quaglia F Porta MG	2015	Mediterr J Hematol Infect Dis2015，7，20：	1
16	The genetic basis of myelodysplasia and its clinical relevance显示文摘	Cazzola M Della Porta MG Malcovati L	2013	Blood2013，122，25：	1
17	Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome显示文摘	Della Porta MG Malcovati L Strupp C	2011	Haematologica2011，96，3：	1
18	Gene polymorphisms in folate metabolizing enzymes in aduh acute lymphoblastic leukemia: Effects on methotrexate-related toxicity and survival 显示文摘	ONGARO A de MATTEI M DELLA PORTA MG	2009	Haematologica2009，94，10：	1
19	Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia:effects on methotrexate-related toxicity and survival显示文摘	Ongaro A De Mattei M Della Porta MG	2009	Haematologica2009，94，10：	1
20	Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)显示文摘	Malcovati L Della Porta MG Strupp C		0，，10：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示